| Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Journal Article
- Language: English
- [Chem Biol Drug Des] 2024 Jun; Vol. 103 (6), pp. e14562.
- MeSH Terms: Polyunsaturated Alkamides* / pharmacology ; Polyunsaturated Alkamides* / chemistry ; Benzodioxoles* / pharmacology ; Benzodioxoles* / chemistry ; Alkaloids* / pharmacology ; Alkaloids* / chemistry ; Piperidines* / pharmacology ; Piperidines* / chemistry ; Docetaxel* / pharmacology ; Signal Transduction* / drug effects ; Drug Resistance, Neoplasm* / drug effects ; Prostatic Neoplasms* / drug therapy ; Prostatic Neoplasms* / metabolism ; Prostatic Neoplasms* / pathology ; Apoptosis* / drug effects ; Cell Movement* / drug effects ; Humans ; Male ; Cell Line, Tumor ; Receptors, Notch / metabolism ; Antineoplastic Agents / pharmacology ; Antineoplastic Agents / chemistry ; Cell Survival / drug effects ; Receptor, Notch1 / metabolism
- References: Benayad, S., Wahnou, H., El Kebbaj, R., Liagre, B., Sol, V., Oudghiri, M., Saad, E. M., Duval, R. E., & Limami, Y. (2023). The promise of Piperine in cancer chemoprevention. Cancers, 15, 5488. https://doi.org/10.3390/cancers15225488. ; Cristofani, R., Montagnani Marelli, M., Cicardi, M. E., Fontana, F., Marzagalli, M., Limonta, P., Poletti, A., & Moretti, R. M. (2018). Dual role of autophagy on docetaxel‐sensitivity in prostate cancer cells. Cell Death & Disease, 9, 889. https://doi.org/10.1038/s41419‐018‐0866‐5. ; Cui, D., Dai, J., Keller, J. M., Mizokami, A., Xia, S., & Keller, E. T. (2015). Notch pathway inhibition using PF‐03084014, a γ‐secretase inhibitor (GSI), enhances the antitumor effect of docetaxel in prostate cancer. Clinical Cancer Research, 21, 4619–4629. https://doi.org/10.1158/1078‐0432.Ccr‐15‐0242. ; Domingo‐Domenech, J., Vidal, S. J., Rodriguez‐Bravo, V., Castillo‐Martin, M., Quinn, S. A., Rodriguez‐Barrueco, R., Bonal, D. M., Charytonowicz, E., Gladoun, N., de la Iglesia‐Vicente, J., Petrylak, D. P., Benson, M. C., Silva, J. M., & Cordon‐Cardo, C. (2012). Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch‐ and hedgehog‐dependent tumor‐initiating cells. Cancer Cell, 22, 373–388. https://doi.org/10.1016/j.ccr.2012.07.016. ; Han, E. J., Choi, E. Y., Jeon, S. J., Lee, S. W., Moon, J. M., Jung, S. H., & Jung, J. Y. (2023). Piperine induces apoptosis and autophagy in HSC‐3 human Oral cancer cells by regulating PI3K signaling pathway. International Journal of Molecular Sciences, 24, 13949. https://doi.org/10.3390/ijms241813949. ; Han, J., Zhang, S., He, J., & Li, T. (2023). Piperine: Chemistry and biology. Toxins, 15(12), 696. https://doi.org/10.3390/toxins15120696. ; Haq, I. U., Imran, M., Nadeem, M., Tufail, T., Gondal, T. A., & Mubarak, M. S. (2021). Piperine: A review of its biological effects. Phytotherapy Research, 35, 680–700. https://doi.org/10.1002/ptr.6855. ; Hashemi, M., Zandieh, M. A., Talebi, Y., Rahmanian, P., Shafiee, S. S., Nejad, M. M., Babaei, R., Sadi, F. H., Rajabi, R., Abkenar, Z. O., Rezaei, S., Ren, J., Nabavi, N., Khorrami, R., Rashidi, M., Hushmandi, K., Entezari, M., & Taheriazam, A. (2023). Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies. Biomedicine & Pharmacotherapy, 160, 114392. https://doi.org/10.1016/j.biopha.2023.114392. ; Huang, J., Chen, Y., Li, J., Zhang, K., Chen, J., Chen, D., Feng, B., Song, H., Feng, J., Wang, R., & Chen, L. (2016). Notch‐1 confers chemoresistance in lung adenocarcinoma to Taxanes through AP‐1/microRNA‐451 mediated regulation of MDR‐1. Molecular Therapy – Nucleic Acids, 5, e375. https://doi.org/10.1038/mtna.2016.82. ; Jiang, X., Guo, S., Xu, M., Ma, B., Liu, R., Xu, Y., & Zhang, Y. (2022). TFAP2C‐mediated lncRNA PCAT1 inhibits ferroptosis in docetaxel‐resistant prostate cancer through c‐Myc/miR‐25‐3p/SLC7A11 signaling. Frontiers in Oncology, 12, 862015. https://doi.org/10.3389/fonc.2022.862015. ; Liu, T., Fan, M. Q., Xie, X. X., Shu, Q. P., Du, X. H., Qi, L. Z., Zhang, X. D., Zhang, M. H., Shan, G., Du, R. L., & Li, S. Z. (2023). Activation of CTNNB1 by deubiquitinase UCHL3‐mediated stabilization facilitates bladder cancer progression. Journal of Translational Medicine, 21, 656. https://doi.org/10.1186/s12967‐023‐04311‐3. ; Lu, X., Yang, F., Chen, D., Zhao, Q., Chen, D., Ping, H., & Xing, N. (2020). Quercetin reverses docetaxel resistance in prostate cancer via androgen receptor and PI3K/Akt signaling pathways. International Journal of Biological Sciences, 16, 1121–1134. https://doi.org/10.7150/ijbs.41686. ; Makhov, P., Golovine, K., Canter, D., Kutikov, A., Simhan, J., Corlew, M. M., Uzzo, R. G., & Kolenko, V. M. (2012). Co‐administration of piperine and docetaxel results in improved anti‐tumor efficacy via inhibition of CYP3A4 activity. Prostate, 72, 661–667. https://doi.org/10.1002/pros.21469. ; Milinkovic, I., Djinic Krasavcevic, A., Nikolic, N., Aleksic, Z., Carkic, J., Jezdic, M., Jankovic, S., & Milasin, J. (2021). Notch down‐regulation and inflammatory cytokines and RANKL overexpression involvement in peri‐implant mucositis and peri‐implantitis: A cross‐sectional study. Clinical Oral Implants Research, 32, 1496–1505. https://doi.org/10.1111/clr.13850. ; Mine, T., Matsueda, S., Gao, H., Li, Y., Wong, K. K., Peoples, G. E., Ferrone, S., & Ioannides, C. G. (2010). Created Gli‐1 duplex short‐RNA (i‐Gli‐RNA) eliminates CD44 Hi progenitors of taxol‐resistant ovarian cancer cells. Oncology Reports, 23, 1537–1543. https://doi.org/10.3892/or_00000793. ; Nayana, P., Manjunatha, H., Gollapalli, P., Ashok, A. K., Karal Andrade, P., & Vijayalaksmi, V. (2024). A combined in vitro and molecular dynamics simulation studies unveil the molecular basis of the anticancer potential of piperine targeting AKT1 against prostate cancer. Journal of Biomolecular Structure & Dynamics, 42, 3616–3629. https://doi.org/10.1080/07391102.2023.2220045. ; O'Neill, A. J., Prencipe, M., Dowling, C., Fan, Y., Mulrane, L., Gallagher, W. M., O'Connor, D., O'Connor, R., Devery, A., Corcoran, C., Rani, S., O'Driscoll, L., Fitzpatrick, J. M., & Watson, R. W. (2011). Characterisation and manipulation of docetaxel resistant prostate cancer cell lines. Molecular Cancer, 10, 126. https://doi.org/10.1186/1476‐4598‐10‐126. ; Ouyang, D. Y., Zeng, L. H., Pan, H., Xu, L. H., Wang, Y., Liu, K. P., & He, X. H. (2013). Piperine inhibits the proliferation of human prostate cancer cells via induction of cell cycle arrest and autophagy. Food and Chemical Toxicology, 60, 424–430. https://doi.org/10.1016/j.fct.2013.08.007. ; Phillips, T. M., McBride, W. H., & Pajonk, F. (2006). The response of CD24(−/low)/CD44+ breast cancer‐initiating cells to radiation. Journal of the National Cancer Institute, 98, 1777–1785. https://doi.org/10.1093/jnci/djj495. ; Qiu, S., Deng, L., Bao, Y., Jin, K., Tu, X., Li, J., Liao, X., Liu, Z., Yang, L., & Wei, Q. (2018). Reversal of docetaxel resistance in prostate cancer by Notch signaling inhibition. Anti‐Cancer Drugs, 29, 871–879. https://doi.org/10.1097/cad.0000000000000659. ; Quijia, C. R., & Chorilli, M. (2022). Piperine for treating breast cancer: A review of molecular mechanisms, combination with anticancer drugs, and nanosystems. Phytotherapy Research, 36, 147–163. https://doi.org/10.1002/ptr.7291. ; Rice, M. A., Hsu, E.‐C., Aslan, M., Ghoochani, A., Su, A., & Stoyanova, T. (2019). Loss of Notch1 activity inhibits prostate cancer growth and metastasis and sensitizes prostate cancer cells to antiandrogen therapies. Molecular Cancer Therapeutics, 18, 1230–1242. https://doi.org/10.1158/1535‐7163.MCT‐18‐0804. ; Rios‐Colon, L., Chijioke, J., Niture, S., Afzal, Z., Qi, Q., Srivastava, A., Ramalinga, M., Kedir, H., Cagle, P., Arthur, E., Sharma, M., Moore, J., Deep, G., Suy, S., Collins, S. P., & Kumar, D. (2022). Leptin modulated microRNA‐628‐5p targets Jagged‐1 and inhibits prostate cancer hallmarks. Scientific Reports, 12, 10073. https://doi.org/10.1038/s41598‐022‐13279‐x. ; Rizzo, M. (2021). Mechanisms of docetaxel resistance in prostate cancer: The key role played by miRNAs. Biochimica et Biophysica Acta. Reviews on Cancer, 1875, 188481. https://doi.org/10.1016/j.bbcan.2020.188481. ; Sato, J., Nakano, K., & Miyazaki, H. (2023). Decreased intracellular chloride enhances cell migration and invasion via activation of the ERK1/2 signaling pathway in DU145 human prostate carcinoma cells. Biochemical and Biophysical Research Communications, 685, 149170. https://doi.org/10.1016/j.bbrc.2023.149170. ; Shi, F., Sun, M.‐H., Zhou, Z., Wu, L., Zhu, Z., Xia, S. J., Han, B. M., Zhao, Y. Y., Jing, Y. F., & Cui, D. (2022). Tumor‐associated macrophages in direct contact with prostate cancer cells promote malignant proliferation and metastasis through NOTCH1 pathway. International Journal of Biological Sciences, 18, 5994–6007. https://doi.org/10.7150/ijbs.73141. ; Steg, A. D., Katre, A. A., Goodman, B., Han, H. D., Nick, A. M., Stone, R. L., Coleman, R. L., Alvarez, R. D., Lopez‐Berestein, G., Sood, A. K., & Landen, C. N. (2011). Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer. Clinical Cancer Research, 17, 5674–5685. https://doi.org/10.1158/1078‐0432.Ccr‐11‐0432. ; Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71, 209–249. https://doi.org/10.3322/caac.21660. ; Tannock, I. F., de Wit, R., Berry, W. R., Horti, J., Pluzanska, A., Chi, K. N., Oudard, S., Théodore, C., James, N. D., Turesson, I., Rosenthal, M. A., & Eisenberger, M. A. (2004). Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. The New England Journal of Medicine, 351, 1502–1512. https://doi.org/10.1056/NEJMoa040720. ; Wang, L., Zi, H., Luo, Y., Liu, T., Zheng, H., Xie, C., Wang, X., & Huang, X. (2020). Inhibition of Notch pathway enhances the anti‐tumor effect of docetaxel in prostate cancer stem‐like cells. Stem Cell Research & Therapy, 11, 258. https://doi.org/10.1186/s13287‐020‐01773‐w. ; Ward, A. B., Mir, H., Kapur, N., Gales, D. N., Carriere, P. P., & Singh, S. (2018). Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti‐apoptotic pathways. World Journal of Surgical Oncology, 16, 108. https://doi.org/10.1186/s12957‐018‐1400‐z. ; Ye, Z., Deng, X., Zhang, J., Shao, R., Song, C., Zhao, J., & Tang, H. (2024). Causal relationship between immune cells and prostate cancer: A Mendelian randomization study. Frontiers in Cell and Development Biology, 12, 1381920. https://doi.org/10.3389/fcell.2024.1381920. ; Younes, M., Mardirossian, R., Rizk, L., Fazlian, T., Khairallah, J. P., Sleiman, C., Naim, H. Y., & Rizk, S. (2022). The synergistic effects of curcumin and chemotherapeutic drugs in inhibiting metastatic, invasive and proliferative pathways. Plants, 11, 2137. https://doi.org/10.3390/plants11162137. ; Zeng, Y., & Yang, Y. (2018). Piperine depresses the migration progression via downregulating the Akt/mTOR/MMP‐9 signaling pathway in DU145 cells. Molecular Medicine Reports, 17, 6363–6370. https://doi.org/10.3892/mmr.2018.8653. ; Zhou, Z., Qin, J., Song, C., Wu, T., Quan, Q., Zhang, Y., Zou, Y., Liu, L., Tang, H., & Zhao, J. (2023). circROBO1 promotes prostate cancer growth and enzalutamide resistance via accelerating glycolysis. Journal of Cancer, 14, 2574–2584. https://doi.org/10.7150/jca.86940.
- Contributed Indexing: Keywords: Notch signaling pathway; chemoresistance; docetaxel; piperine; prostate cancer
- Substance Nomenclature: 0 (Polyunsaturated Alkamides) ; U71XL721QK (piperine) ; 0 (Benzodioxoles) ; 0 (Alkaloids) ; 0 (Piperidines) ; 15H5577CQD (Docetaxel) ; 0 (Receptors, Notch) ; 0 (Antineoplastic Agents) ; 0 (Receptor, Notch1)
- Entry Date(s): Date Created: 20240619 Date Completed: 20240619 Latest Revision: 20240619
- Update Code: 20240620
|
